• VOGX share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • VOGX stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • VOGX market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

About VOGX

Vogenx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery and development of treatments for serious metabolic and gastrointestinal diseases. The company was founded by James Green, William Wilkison, and Steven Delmar on February 5, 2021 and is headquartered in Raleigh, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

  • VOGX market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Smart score

Latest VOGX news

No recent TipRanks articles are available for VOGX

No recent press releases are available for VOGX

VOGX Financials

1-year income & revenue

  • VOGX total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • VOGX net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • VOGX earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

VOGX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VOGX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    VOGX's competitors are included in the Health Technology sector and Biotechnology group

  • VOGX market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Latest investing news